Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
125.08
-0.32 (-0.26%)
At close: Dec 5, 2025, 4:00 PM EST
125.26
+0.18 (0.14%)
After-hours: Dec 5, 2025, 7:55 PM EST
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of $217.50 billion as of December 5, 2025. Its market cap has increased by 7.06% in one year.
Market Cap
217.50B
Enterprise Value
222.74B
1-Year Change
7.06%
Ranking
Category
Stock Price
$125.08
Market Cap Chart
Since December 1, 1998, Abbott Laboratories's market cap has increased from $72.66B to $217.50B, an increase of 199.32%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 217.50B | 10.86% |
| Dec 31, 2024 | 196.18B | 2.67% |
| Dec 29, 2023 | 191.09B | -0.18% |
| Dec 30, 2022 | 191.43B | -23.08% |
| Dec 31, 2021 | 248.87B | 28.25% |
| Dec 31, 2020 | 194.06B | 26.33% |
| Dec 31, 2019 | 153.61B | 20.92% |
| Dec 31, 2018 | 127.04B | 27.88% |
| Dec 29, 2017 | 99.34B | 75.66% |
| Dec 30, 2016 | 56.55B | -15.59% |
| Dec 31, 2015 | 66.99B | -1.18% |
| Dec 31, 2014 | 67.79B | 14.39% |
| Dec 31, 2013 | 59.27B | -42.76% |
| Dec 31, 2012 | 103.53B | 18.20% |
| Dec 30, 2011 | 87.59B | 18.28% |
| Dec 31, 2010 | 74.06B | -11.31% |
| Dec 31, 2009 | 83.51B | 0.85% |
| Dec 31, 2008 | 82.81B | -4.56% |
| Dec 31, 2007 | 86.77B | 16.06% |
| Dec 29, 2006 | 74.76B | 22.23% |
| Dec 30, 2005 | 61.16B | -15.81% |
| Dec 31, 2004 | 72.65B | -0.27% |
| Dec 31, 2003 | 72.85B | 16.56% |
| Dec 31, 2002 | 62.50B | -27.79% |
| Dec 31, 2001 | 86.55B | 15.52% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Thermo Fisher Scientific | 215.19B |